Intuitive Surgical, Inc. $ISRG Holdings Raised by Davis R M Inc.

Davis R M Inc. raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 607.8% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 41,614 shares of the medical equipment provider’s stock after buying an additional 35,735 shares during the period. Davis R M Inc.’s holdings in Intuitive Surgical were worth $22,614,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of ISRG. Aaron Wealth Advisors LLC boosted its position in Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after purchasing an additional 19 shares during the last quarter. J. W. Coons Advisors LLC raised its stake in shares of Intuitive Surgical by 1.4% during the 1st quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock worth $741,000 after purchasing an additional 20 shares in the last quarter. Exencial Wealth Advisors LLC lifted its holdings in shares of Intuitive Surgical by 3.1% during the 1st quarter. Exencial Wealth Advisors LLC now owns 661 shares of the medical equipment provider’s stock valued at $327,000 after buying an additional 20 shares during the last quarter. Evergreen Capital Management LLC grew its stake in shares of Intuitive Surgical by 0.5% in the 1st quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock valued at $2,124,000 after buying an additional 20 shares in the last quarter. Finally, Rise Advisors LLC grew its stake in shares of Intuitive Surgical by 5.6% in the 1st quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock valued at $187,000 after buying an additional 20 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

Shares of ISRG opened at $560.00 on Monday. The company has a market capitalization of $200.75 billion, a PE ratio of 74.07, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The company’s fifty day moving average price is $471.89 and its 200 day moving average price is $501.11.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same period in the prior year, the company earned $1.84 earnings per share. Analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity

In other Intuitive Surgical news, CEO David J. Rosa sold 24,500 shares of the firm’s stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.55, for a total value of $13,414,975.00. Following the sale, the chief executive officer owned 234,256 shares of the company’s stock, valued at $128,266,872.80. This trade represents a 9.47% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP Fredrik Widman sold 2,067 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $550.00, for a total value of $1,136,850.00. Following the completion of the transaction, the vice president directly owned 473 shares in the company, valued at approximately $260,150. This represents a 81.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 98,078 shares of company stock worth $51,445,892 over the last 90 days. Company insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of analyst reports. Robert W. Baird set a $655.00 target price on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. UBS Group set a $600.00 price objective on shares of Intuitive Surgical and gave the company a “neutral” rating in a research note on Thursday, October 23rd. Leerink Partners upped their price objective on shares of Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Jefferies Financial Group raised their target price on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a report on Wednesday, October 22nd. Finally, Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday. Two analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.